(Q39231933)

10 September 2017

title

Pharmacological augmentation of acetylcholine levels in kainate-lesioned rat striatum (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

2 April 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

2 April 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

2 April 2022

author name string

E. D. London

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A32892

2 April 2022

J. T. Coyle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A32892

2 April 2022

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

10 September 2017

https://api.elsevier.com/content/article/PII:0006295278902186?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

https://api.elsevier.com/content/article/PII:0006295278902186?httpAccept=text/plain

2 April 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

2 April 2022

published in

Biochemical Pharmacology

1 reference

10 September 2017

volume

27

1 reference

10 September 2017

issue

24

1 reference

10 September 2017

page(s)

2962-2965

1 reference

Actions of several anthelmintics and insecticides on rat cortical neurones

10 September 2017

cites work

1

24

368

Shinozaki

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

2 April 2022

Striatal lesions with kainic acid: neurochemical characteristics

2

0 references

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease1

29 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage

29 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia

29 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain

29 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: Correlates with a new animal model

29 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea

29 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Modification of Parkinsonism--chronic treatment with L-dopa

29 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Central cholinergic-anticholinergic antagonism in Huntington's chorea

29 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Choline in tardive dyskinesia and Huntington's disease

29 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Brain acetylcholine: Increase after systematic choline administration

29 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Increase in rat brain acetylcholine induced by choline or deanol

29 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Huntington's disease: Clinical and chemical effects of choline administration

29 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Physostigmine in choreiform movement disorders

29 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

The determination of picomole amounts of acetylcholine in mammalian brain

29 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods

29 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

29 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+)-amphetamine

29 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Choline and acetylcholine: Regional distribution and effect of degeneration of cholinergic nerve terminals in the rat hippocampus

29 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Effects of anesthetics and septal lesions and stimulation on 3H-acetylcholine formation in rat hippocampus

29 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Inhibitors of GABA metabolism: Implications for Huntington's disease

29 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea

29 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-2952(78)90218-6

29 October 2022

Identifiers

1 reference

10 September 2017

1 reference